Results 201 to 210 of about 43,529 (272)

X-linked hypophosphatemia and tumor-induced osteomalacia: a narrative review and expert opinion on the diagnostic and therapeutic challenges in the era of burosumab. [PDF]

Orphanet J Rare Dis
Brandi ML, Vainicher CE, Fintini D, Giusti A, Magnolato A, Minisola S, Giannini S.   +6 more
europepmc   +1 more source

Osteoporosis Associated with <i>SCN8A</i> Mutation. [PDF]

JCEM Case Rep
Khurram D, Kupkova K, Mesner LD, Kraftson AT, Farber CR, Clines GA.   +5 more
europepmc   +1 more source

Improvement in Physical Function Associated With Burosumab in a Patient With X-linked Hypophosphatemia: A Case Report. [PDF]

Cureus
Fukushima M, Hashida R, Matsuse H, Hiraoka K.   +3 more
europepmc   +1 more source

Refractory Hypophosphatemia Secondary to Tumor-Induced Osteomalacia: Diagnostic Challenges and Successful Management With Burosumab. [PDF]

Cureus
Ramzan A, Lodhi FAK, Ramzan F.
europepmc   +1 more source

Bone Scintigraphy and Laboratory Clues to Osteomalacia in a Middle-Aged Man With Hip Fractures. [PDF]

Clin Nucl Med
Chuang TL, Wang YF.
europepmc   +1 more source

Osteomalacia.

JPMA. The Journal of the Pakistan Medical Association, 1980
openaire   +1 more source

Tumour-induced osteomalacia

Nature Reviews Disease Primers, 2017
Salvatore Minisola, Seijii Fukumoto, Cristiana Cipriani   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Osteomalacia

Vnitřní lékařství, 2023
Osteomalacia with characteristic histomorphometric, radiographic, laboratory and clinical features is a prominent syndrome of disturbed bone mineralisation in adulthood. From an etiological point of view, osteomalacia is usually caused by substrate (calcium, phosphate) deficiency, presence of excess mineralization inhibitors or deficiency or ...
openaire   +2 more sources